Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-20

Clinical Trial Update: Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating botulinum toxin injections for thumb carpometacarpal osteoarthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Carpometacarpal Sprain, Thumb Sprain | Phase 3 | Status: RECRUITING